495 related articles for article (PubMed ID: 26878648)
1. Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment.
Jacobs R; Tshehla E; Malherbe S; Kriel M; Loxton AG; Stanley K; van der Spuy G; Walzl G; Chegou NN
Cytokine; 2016 May; 81():50-6. PubMed ID: 26878648
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Potential of Novel Salivary Host Biomarkers as Candidates for the Immunological Diagnosis of Tuberculosis Disease and Monitoring of Tuberculosis Treatment Response.
Jacobs R; Maasdorp E; Malherbe S; Loxton AG; Stanley K; van der Spuy G; Walzl G; Chegou NN
PLoS One; 2016; 11(8):e0160546. PubMed ID: 27487181
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response.
Jacobs R; Malherbe S; Loxton AG; Stanley K; van der Spuy G; Walzl G; Chegou NN
Oncotarget; 2016 Sep; 7(36):57581-57592. PubMed ID: 27557501
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals.
Manngo PM; Gutschmidt A; Snyders CI; Mutavhatsindi H; Manyelo CM; Makhoba NS; Ahlers P; Hiemstra A; Stanley K; McAnda S; Kidd M; Malherbe ST; Walzl G; Chegou NN
J Infect; 2019 Sep; 79(3):228-235. PubMed ID: 31319143
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB.
Chegou NN; Sutherland JS; Malherbe S; Crampin AC; Corstjens PL; Geluk A; Mayanja-Kizza H; Loxton AG; van der Spuy G; Stanley K; Kotzé LA; van der Vyver M; Rosenkrands I; Kidd M; van Helden PD; Dockrell HM; Ottenhoff TH; Kaufmann SH; Walzl G;
Thorax; 2016 Sep; 71(9):785-94. PubMed ID: 27146200
[TBL] [Abstract][Full Text] [Related]
6. Host urine immunological biomarkers as potential candidates for the diagnosis of tuberculosis.
Eribo OA; Leqheka MS; Malherbe ST; McAnda S; Stanley K; van der Spuy GD; Walzl G; Chegou NN
Int J Infect Dis; 2020 Oct; 99():473-481. PubMed ID: 32800854
[TBL] [Abstract][Full Text] [Related]
7. A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries.
Chendi BH; Snyders CI; Tonby K; Jenum S; Kidd M; Walzl G; Chegou NN; Dyrhol-Riise AM
Front Immunol; 2021; 12():608846. PubMed ID: 33732236
[No Abstract] [Full Text] [Related]
8. Baseline and end-of-treatment host serum biomarkers predict relapse in adults with pulmonary tuberculosis.
Mutavhatsindi H; Manyelo CM; Snyders CI; Van Rensburg I; Kidd M; Stanley K; Tromp G; Dietze R; Thiel B; van Helden PD; Belisle JT; Johnson JL; Boom WH; Walzl G; Chegou NN
J Infect; 2024 Jul; 89(1):106173. PubMed ID: 38734311
[TBL] [Abstract][Full Text] [Related]
9. Candidate Biomarkers to Distinguish Spinal Tuberculosis From Mechanical Back Pain in a Tuberculosis Endemic Setting.
Mann TN; Davis JH; Walzl G; Beltran CG; du Toit J; Lamberts RP; Chegou NN
Front Immunol; 2021; 12():768040. PubMed ID: 34868023
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel salivary candidate protein biomarkers for tuberculosis diagnosis: A preliminary biomarker discovery study.
Mutavhatsindi H; Calder B; McAnda S; Malherbe ST; Stanley K; Kidd M; Walzl G; Chegou NN
Tuberculosis (Edinb); 2021 Sep; 130():102118. PubMed ID: 34371310
[TBL] [Abstract][Full Text] [Related]
11. Cytokine Kinetics in the First Week of Tuberculosis Therapy as a Tool to Confirm a Clinical Diagnosis and Guide Therapy.
den Hertog AL; Montero-Martín M; Saunders RL; Blakiston M; Menting S; Sherchand JB; Lawson L; Oladimeji O; Abdurrahman ST; Cuevas LE; Anthony RM
PLoS One; 2015; 10(6):e0129552. PubMed ID: 26115421
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of host protein biomarkers among symptomatic clinic attendees finally diagnosed with tuberculosis and other respiratory diseases with or without latent Mycobacterium tuberculosis infection.
Namuganga AR; Nsereko M; Bagaya BS; Mayanja-Kizza H; Chegou NN
Immunol Lett; 2023 Jan; 253():8-18. PubMed ID: 36463987
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
[TBL] [Abstract][Full Text] [Related]
14. Profiling the human immune response to Mycobacterium tuberculosis by human cytokine array.
Chen T; Li Z; Yu L; Li H; Lin J; Guo H; Wang W; Chen L; Zhang X; Wang Y; Chen Y; Liao Q; Tan Y; Shu Y; Huang W; Cai C; Zhou Z; Yu M; Li G; Zhou L; Zhong Q; Bi L; Zhao M; Guo L; Zhou J
Tuberculosis (Edinb); 2016 Mar; 97():108-17. PubMed ID: 26980502
[TBL] [Abstract][Full Text] [Related]
15. Suitability of saliva for Tuberculosis diagnosis: comparing with serum.
Namuganga AR; Chegou NN; Mubiri P; Walzl G; Mayanja-Kizza H
BMC Infect Dis; 2017 Aug; 17(1):600. PubMed ID: 28859607
[TBL] [Abstract][Full Text] [Related]
16. Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis.
Chegou NN; Sutherland JS; Namuganga AR; Corstjens PL; Geluk A; Gebremichael G; Mendy J; Malherbe S; Stanley K; van der Spuy GD; Kriel M; Loxton AG; Kriel B; Simukonda F; Bekele Y; Sheehama JA; Nelongo J; van der Vyver M; Gebrexabher A; Hailu H; Esterhuyse MM; Rosenkrands I; Aagard C; Kidd M; Kassa D; Mihret A; Howe R; Cliff JM; Crampin AC; Mayanja-Kizza H; Kaufmann SHE; Dockrell HM; Ottenhoff THM; Walzl G;
Sci Rep; 2018 Feb; 8(1):2675. PubMed ID: 29422548
[TBL] [Abstract][Full Text] [Related]
17. Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.
Jayakumar A; Vittinghoff E; Segal MR; MacKenzie WR; Johnson JL; Gitta P; Saukkonen J; Anderson J; Weiner M; Engle M; Yoon C; Kato-Maeda M; Nahid P;
Tuberculosis (Edinb); 2015 Jul; 95(4):415-20. PubMed ID: 26022314
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of an integrated respiratory guideline in identifying patients with respiratory symptoms requiring screening for pulmonary tuberculosis: a cross-sectional study.
English RG; Bachmann MO; Bateman ED; Zwarenstein MF; Fairall LR; Bheekie A; Majara BP; Lombard C; Scherpbier R; Ottomani SE
BMC Pulm Med; 2006 Aug; 6():22. PubMed ID: 16934140
[TBL] [Abstract][Full Text] [Related]
20. Differential Levels of Alpha-2-Macroglobulin, Haptoglobin and Sero-Transferrin as Adjunct Markers for TB Diagnosis and Disease Progression in the Malnourished Tribal Population of Melghat, India.
Bapat PR; Satav AR; Husain AA; Shekhawat SD; Kawle AP; Chu JJ; Purohit HJ; Daginawala HF; Taori GM; Kashyap RS
PLoS One; 2015; 10(8):e0133928. PubMed ID: 26241963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
